Earnings Feed
Start Free
Insight Molecular Diagnostics Inc.·4

Apr 27, 7:08 PM ET

BROADWOOD PARTNERS, L.P. 4

Research Summary

AI-generated summary

Updated

IMDX — Broadwood Partners (10% Owner) Buys Stock

What Happened
Broadwood Partners, L.P. (reported as a 10% owner) made open-market purchases of Insight Molecular Diagnostics, Inc. (IMDX) common stock on April 23, 24 and 27, 2026. The filing shows 280,381 shares at $3.50 (≈$982,034) on Apr 23; 38,880 shares at $3.53 (≈$137,083) on Apr 24; and 250,923 shares at $3.64 (≈$913,134) on Apr 27 — a total of 570,184 shares purchased for approximately $2,032,251. These were purchases (P), which are generally interpreted as insider/owner buying shares rather than selling.

Key Details

  • Transaction dates and reported prices:
    • 2026-04-23: 280,381 shares @ $3.50 (≈ $982,034)
    • 2026-04-24: 38,880 shares @ $3.53 (≈ $137,083)
    • 2026-04-27: 250,923 shares @ $3.64 (≈ $913,134)
  • Total shares acquired: 570,184; total cash spent: ≈ $2.03 million.
  • Shares owned after transaction: Not specified in the provided summary of the filing.
  • Notable footnotes:
    • F1: Securities are directly owned by Broadwood Partners, L.P.; Broadwood Capital, Inc. (general partner) and Neal C. Bradsher (president of Broadwood Capital) may be deemed beneficial owners but disclaim beneficial ownership except for pecuniary interest.
    • F3–F5: The filing reports weighted-average purchase prices and notes the actual per-share prices ranged across the trades (rough ranges reported: $3.39–$3.84); full per-price breakdown available on request to the SEC staff or issuer.
    • F6: Mentions warrants are currently exercisable (not directly tied to the listed purchases).
  • Filing date: Report filed with the SEC Apr 27, 2026, covering purchases made Apr 23–27, 2026. (Check the official Form 4 for any timeliness designation.)

Context

  • This activity is by a 10% institutional owner (Broadwood Partners), not an individual company executive; such institutional purchases can reflect portfolio or investment decisions rather than executive-level trading signals.
  • Purchases (code P) are generally more informative to retail investors than routine sales because they indicate capital deployed to accumulate stock; the filing provides weighted-average price ranges and offers more granular price details to regulators or holders on request.